Selective opioid receptor agonist and antagonist displacement of [3H]naloxone binding in amphibian brain

European Journal of Pharmacology

Volumn 397, Issue 2-3, 2000, Pages 255-262

  Newman, Leslie C ^a   Wallace, David R ^a   Stevens, Craig W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Amphibian; Antinociception; Opioid receptor; 3H Naloxone

Indexed keywords

KAPPA OPIATE RECEPTOR ANTAGONIST; NALOXONE; OPIATE RECEPTOR;

AMPHIBIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN; CONTROLLED STUDY; LIGAND BINDING; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BINDING, COMPETITIVE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RADIOLIGAND ASSAY; RANA PIPIENS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TRITIUM;

EID: 0034595733     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00265-X     Document Type: Article

References (34)

1. Benyhe S., Varga E., Hepp J., Magyar A., Borsodi A., Wollemann M. Characterization of kappa1 and kappa2 opioid binding sites in frog (Rana esculenta) brain membrane. Neurochem. Res. 15:1990;899-904.
2. Blurton P.A., Broadhurst A.M., Wood M.D., Wyllie M.G. Is there a common, high-affinity opioid binding site in rat brain? J. Recept. Res. 6:1986;85-93.
3. Broadbear J.H., Negus S.S., Butelman E.R., De Costa B.R., Woods J.H. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology. 115:1994;311-319.
4. Buatti M.C., Pasternak G.W. Multiple opiate receptors: phylogenetic differences. Brain Res. 218:1981;400-405.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
6. Deviche P., Murray T.F., Moore F.L. Effects of sodium and temperature on naloxone binding in brain tissues of a urodele amphibian. Comp. Biochem. Physiol. 96C:1990;393-398.
7. Gillan M.G.C., Kosterlitz H.W., Paterson S.J. Comparison of the binding characteristics of tritiated opiates and opioid peptides. Br. J. Pharmacol. 70:1980;481-490.
8. Horan P.J., De Costa B.R., Rice K., Haaseth R.C., Hruby V.J., Porreca F. Differential antagonism of bremazocine and U69, 593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse. J. Pharmacol. Exp. Ther. 266:1993;926-933.
9. 3H]naloxone) binding to hypothalamic and cerebral cortical slices of mouse brain. Brain Res. Bull. 13:1984;481-485.
10. Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 267:1977;495-499.
11. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
12. Mollereau C., Pascaud A., Baillat G., Mazarguil H., Puget A., Meunier J.C. Evidence for a new type of opioid binding site in the brain of the frog Rana ridibunda. Eur. J. Pharmacol. 150:1988;75-84.
13. 3H-diprenorphine binding in Rana pipiens: observations of filter binding enhanced by naltrexone. J. Pharmacol. Toxicol. Methods. 41:1999;43-48.
14. Pert C.B., Snyder S.H. Properties of opiate-receptor binding in rat brain. Proc. Natl. Acad. Sci. U. S. A. 70:1973;2243-2247.
15. Pert C.B., Aposhian D., Snyder S.H. Phylogenetic distribution of opiate binding. Brain Res. 75:1974;356-361.
16. Pezalla P.D. Morphine-induced analgesia and explosive motor behavior in an amphibian. Brain Res. 273:1983;297-305.
17. Pfeiffer A., Herz A. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique. Mol. Pharmacol. 21:1982;266-271.
18. 3Hnaloxone binding sites. Life Sci. 41:1987;385-390.
19. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
20. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
21. Satoh M., Minami M. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68:1995;343-364.
22. 3H]-Naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues. Biomed. Biochim. Acta. 49:1990;209-218.
23. Simon E.J., Hiller J.M., Groth J., Itzhak Y., Holland M.J., Beck S.G. The nature of opiate receptors in toad brain. Life Sci. 31:1982;1367-1370.
24. Simon J., Szucs M., Benyhe S., Borsodi A., Zemlan F.P., Wollemann M. Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain. J. Neurochem. 43:1984;957-963.
25. Stevens C.W. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians. J. Pharmacol. Exp. Ther. 276:1996;440-448.
26. Stevens C.W., Newman L.C. Spinal administration of selective opioid antagonists in amphibians: evidence for an opioid unireceptor. Life Sci. 64:1999;PL125-PL130.
27. Stevens C.W., Pezalla P.D. A spinal site mediates opiate analgesia in frogs. Life Sci. 33:1983;2097-2103.
28. Stevens C.W., Pezalla P.D. Naloxone blocks the analgesic action of levorphanol but not of dextrorphan in the leopard frog. Brain Res. 301:1984;171-174.
29. Stevens C.W., Rothe-Skinner K. Supraspinal administration of opioids with selectivity for μ-, δ-, and κ-opioid receptors produces analgesia in amphibians. Eur. J. Pharmacol. 331:1997;15-21.
30. Stevens C.W., Klopp A.J., Facello J.A. Analgesic potency of mu and kappa opioids after systemic administration in amphibians. J. Pharmacol. Exp. Ther. 269:1994;1086-1093.
31. 3H]naloxone binding sites in rat brain synaptosomes. Neurochem. Res. 12:1987;581-587.
32. Takemori A.E. Affinity labels for opioid receptors. Ann. Rev. Pharmacol. Toxicol. 25:1985;193-223.
33. Takemori A.E., Portoghese P.S. Selective naltrexone-derived opioid receptor antagonists. Ann. Rev. Pharmacol. Toxicol. 32:1992;239-269.
34. 3H]diprenorphine binding to kappa sites in guinea-pig and rat brain: evidence for apparent heterogeneity. J. Neurochem. 53:1989;173-178.